Myriad Genetics Inc (MYGN)
21.64
+0.48
(+2.27%)
USD |
NASDAQ |
Mar 18, 16:00
21.63
-0.01
(-0.05%)
After-Hours: 20:00
Myriad Genetics Revenue (TTM): 753.20M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 753.20M |
September 30, 2023 | 734.40M |
June 30, 2023 | 698.90M |
March 31, 2023 | 694.70M |
December 31, 2022 | 678.40M |
September 30, 2022 | 661.40M |
June 30, 2022 | 672.30M |
March 31, 2022 | 682.40M |
December 31, 2021 | 690.60M |
September 30, 2021 | 675.00M |
June 30, 2021 | 600.90M |
March 31, 2021 | 575.50M |
September 30, 2020 | 597.50M |
June 30, 2020 | 638.60M |
March 31, 2020 | 760.80M |
December 31, 2019 | 813.40M |
September 30, 2019 | 835.10M |
June 30, 2019 | 851.10M |
March 31, 2019 | 829.60M |
December 31, 2018 | 796.10M |
September 30, 2018 | 767.20M |
June 30, 2018 | 743.70M |
March 31, 2018 | 707.60M |
December 31, 2017 | 721.40M |
September 30, 2017 | 730.00M |
Date | Value |
---|---|
June 30, 2017 | 728.70M |
March 31, 2017 | 744.00M |
December 31, 2016 | 737.60M |
September 30, 2016 | 734.40M |
June 30, 2016 | 740.40M |
March 31, 2016 | 757.20M |
December 31, 2015 | 746.70M |
September 30, 2015 | 737.80M |
June 30, 2015 | 723.10M |
March 31, 2015 | 721.95M |
December 31, 2014 | 724.87M |
September 30, 2014 | 744.53M |
June 30, 2014 | 778.20M |
March 31, 2014 | 763.60M |
December 31, 2013 | 737.15M |
September 30, 2013 | 682.23M |
June 30, 2013 | 613.20M |
March 31, 2013 | 572.01M |
December 31, 2012 | 545.32M |
September 30, 2012 | 518.99M |
June 30, 2012 | 496.00M |
March 31, 2012 | 470.45M |
December 31, 2011 | 443.05M |
September 30, 2011 | 420.68M |
June 30, 2011 | 402.08M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
575.50M
Minimum
Mar 2021
851.10M
Maximum
Jun 2019
707.57M
Average
690.60M
Median
Dec 2021
Revenue (TTM) Benchmarks
Haemonetics Corp | 1.270B |
Stryker Corp | 20.50B |
Integer Holdings Corp | 1.597B |
Perspective Therapeutics Inc | 6.956M |
Electromed Inc | 51.69M |